These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 15328206

  • 1. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
    Vaday GG, Hua SB, Peehl DM, Pauling MH, Lin YH, Zhu L, Lawrence DM, Foda HD, Zucker S.
    Clin Cancer Res; 2004 Aug 15; 10(16):5630-9. PubMed ID: 15328206
    [Abstract] [Full Text] [Related]

  • 2. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H, Matsubara A, Teishima J, Mutaguchi K, Yasumoto H, Dahiya R, Usui T, Kamiya K.
    Biochem Biophys Res Commun; 2004 Jul 30; 320(3):656-63. PubMed ID: 15240098
    [Abstract] [Full Text] [Related]

  • 3. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
    Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS.
    J Cell Biochem; 2003 Jun 01; 89(3):462-73. PubMed ID: 12761880
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC.
    Cancer Res; 2005 Nov 01; 65(21):9891-8. PubMed ID: 16267013
    [Abstract] [Full Text] [Related]

  • 5. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML.
    Prostate; 2006 Jan 01; 66(1):32-48. PubMed ID: 16114056
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H, Mansel RE, Jiang WG.
    Int J Oncol; 2005 May 01; 26(5):1429-34. PubMed ID: 15809737
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
    Burger M, Glodek A, Hartmann T, Schmitt-Gräff A, Silberstein LE, Fujii N, Kipps TJ, Burger JA.
    Oncogene; 2003 Nov 06; 22(50):8093-101. PubMed ID: 14603250
    [Abstract] [Full Text] [Related]

  • 10. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
    Li F, Zhu HS, Han ZQ, Chen G, Gao QL, Jia P, Zhang AL, Xi L, Xu Q, Liao GN, Wang SX, Lu YP, Ma D.
    Ai Zheng; 2005 Jan 06; 24(1):23-7. PubMed ID: 15642195
    [Abstract] [Full Text] [Related]

  • 11. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
    Samara GJ, Lawrence DM, Chiarelli CJ, Valentino MD, Lyubsky S, Zucker S, Vaday GG.
    Cancer Lett; 2004 Oct 28; 214(2):231-41. PubMed ID: 15363550
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M, Patel HR, McGurk C, Tatoud R, Klocker H, Masters J, Williamson M.
    J Exp Ther Oncol; 2004 Dec 28; 4(4):291-303. PubMed ID: 15844659
    [Abstract] [Full Text] [Related]

  • 14. Role of CXCL12 in metastasis of human ovarian cancer.
    Jiang YP, Wu XH, Xing HY, DU XY.
    Chin Med J (Engl); 2007 Jul 20; 120(14):1251-5. PubMed ID: 17697577
    [Abstract] [Full Text] [Related]

  • 15. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
    Vaday GG, Peehl DM, Kadam PA, Lawrence DM.
    Prostate; 2006 Feb 01; 66(2):124-34. PubMed ID: 16161154
    [Abstract] [Full Text] [Related]

  • 16. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX, Schneider A, Jung Y, Wang J, Dai J, Wang J, Cook K, Osman NI, Koh-Paige AJ, Shim H, Pienta KJ, Keller ET, McCauley LK, Taichman RS.
    J Bone Miner Res; 2005 Feb 01; 20(2):318-29. PubMed ID: 15647826
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.
    Cardones AR, Murakami T, Hwang ST.
    Cancer Res; 2003 Oct 15; 63(20):6751-7. PubMed ID: 14583470
    [Abstract] [Full Text] [Related]

  • 19. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL, Zhang JL, Tang SF, Fu QY, Li ZT.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 15; 88(3):202-5. PubMed ID: 18361822
    [Abstract] [Full Text] [Related]

  • 20. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
    Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, Gattegno L, Charnaux N.
    Mol Cancer Res; 2007 Jan 15; 5(1):21-33. PubMed ID: 17259344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.